National security considerations are rapidly reshaping the life sciences industry, with evolving U.S. and European regulations affecting research, clinical trials, supply chains, investment, data ...
Updates and Insights on Quality and Inspections. The newsletter, which will come out roughly monthly, will discuss new developments in FDA inspections and enforcement, and its regulation of ...
In In re Nussbaum Lowinger LLP, the Bankruptcy Court for the Southern District of New York (the Court) dismissed Chapter 11 ...
Exchange Act Rule 14a-8 addresses when a company must include a shareholder’s proposal in its proxy statement for an annual or special meeting of shareholders. In order to have a proposal included, a ...
On August 11, 2026, the U.S. Food and Drug Administration (FDA) published a proposed rule that would convert the currently voluntary Generally Recognized as Safe (GRAS) notification program into a ...
A magistrate judge in the Northern District of California held that a party’s use of generative artificial intelligence (AI) in document review is subject to the same reasonableness and ...
On July 13, 2026, the U.S. Food and Drug Administration (FDA) published a proposed rule that would amend the drug establishment registration and drug listing requirements for establishments engaged in ...
Sunita Bali is the co-chair of the firm’s Privacy, Cybersecurity & Data Strategy group. A seasoned commercial litigator, Sunita Bali represents technology, retail ...
On June 25, 2026, the U.S. Department of Agriculture (USDA) published a proposed rule (Docket No. USDA-2026-0001; RIN 0560-AI70) that would significantly reshape the regulatory framework under the ...
The HHS Office of Inspector General is also evaluating whether to update the safe harbor regulations under the federal Anti-Kickback Statute or the exceptions to the civil monetary penalty provision ...
Arnold & Porter announced today that Stephanie Kang has rejoined the firm’s Complex Litigation practice as counsel, resident in Los Angeles, continuing the firm’s West Coast growth. Stephanie ...
The life sciences sector continues to be a growing area of interest for national security controls, as U.S. pharmaceutical companies have increasingly partnered with Chinese firms for development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results